Clinical Trial Update: Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal) [Phase 2, Phase 3]

View source ↗

Summary

This is a protocol for a randomized adaptive platform trial evaluating pathogen-directed anti-inflammatory therapy for severe community-acquired pneumonia, span…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: Qingyuan Zhan | Conditions: Severe Community-acquired Pneumonia (sCAP) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING